世界のイズロン酸2スルファターゼ市場インサイト及び予測(~2026年)

【英語タイトル】Global Iduronate 2 Sulfatase Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV12299)・商品コード:QYR20NV12299
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはイズロン酸2スルファターゼの世界市場について調査・分析した資料です。種類別(アルファLイズロン酸硫酸スルファターゼ、イデュルスルファーゼ、IDS、EC 3.1.6.13)の市場規模、用途別(病院、外来手術センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別イズロン酸2スルファターゼの競争状況、市場シェア
・世界のイズロン酸2スルファターゼ市場:種類別市場規模 2015年-2020年(アルファLイズロン酸硫酸スルファターゼ、イデュルスルファーゼ、IDS、EC 3.1.6.13)
・世界のイズロン酸2スルファターゼ市場:種類別市場規模予測 2021年-2026年(アルファLイズロン酸硫酸スルファターゼ、イデュルスルファーゼ、IDS、EC 3.1.6.13)
・世界のイズロン酸2スルファターゼ市場:用途別市場規模 2015年-2020年(病院、外来手術センター、その他)
・世界のイズロン酸2スルファターゼ市場:用途別市場規模予測 2021年-2026年(病院、外来手術センター、その他)
・北米のイズロン酸2スルファターゼ市場分析:米国、カナダ
・ヨーロッパのイズロン酸2スルファターゼ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのイズロン酸2スルファターゼ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のイズロン酸2スルファターゼ市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのイズロン酸2スルファターゼ市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AngioChem、ArmaGen、Bioasis Technologies、Green Cross、JCR Pharmaceuticals、Esteve、RegenxBio、Sangamo BioSciences、Takeda
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.
Iduronate 2-sulfatase (IDS) is a sulfatase enzyme associated with Hunter syndrome. Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to Hunter syndrome.

Market Analysis and Insights: Global Iduronate 2 Sulfatase Market
The global Iduronate 2 Sulfatase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Iduronate 2 Sulfatase Scope and Market Size
Iduronate 2 Sulfatase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Iduronate 2 Sulfatase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AngioChem
ArmaGen
Bioasis Technologies
Green Cross
JCR Pharmaceuticals
Esteve
RegenxBio
Sangamo BioSciences
Takeda

Market segment by Type, the product can be split into
Alpha L Iduronate Sulfate Sulfatase
Idursulfase
IDS
EC 3.1.6.13
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Iduronate 2 Sulfatase Revenue
1.4 Market by Type
1.4.1 Global Iduronate 2 Sulfatase Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Alpha L Iduronate Sulfate Sulfatase
1.4.3 Idursulfase
1.4.4 IDS
1.4.5 EC 3.1.6.13
1.5 Market by Application
1.5.1 Global Iduronate 2 Sulfatase Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Iduronate 2 Sulfatase Market Perspective (2015-2026)
2.2 Global Iduronate 2 Sulfatase Growth Trends by Regions
2.2.1 Iduronate 2 Sulfatase Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Iduronate 2 Sulfatase Historic Market Share by Regions (2015-2020)
2.2.3 Iduronate 2 Sulfatase Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Iduronate 2 Sulfatase Market Growth Strategy
2.3.6 Primary Interviews with Key Iduronate 2 Sulfatase Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Iduronate 2 Sulfatase Players by Market Size
3.1.1 Global Top Iduronate 2 Sulfatase Players by Revenue (2015-2020)
3.1.2 Global Iduronate 2 Sulfatase Revenue Market Share by Players (2015-2020)
3.1.3 Global Iduronate 2 Sulfatase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Iduronate 2 Sulfatase Market Concentration Ratio
3.2.1 Global Iduronate 2 Sulfatase Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Iduronate 2 Sulfatase Revenue in 2019
3.3 Iduronate 2 Sulfatase Key Players Head office and Area Served
3.4 Key Players Iduronate 2 Sulfatase Product Solution and Service
3.5 Date of Enter into Iduronate 2 Sulfatase Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Iduronate 2 Sulfatase Historic Market Size by Type (2015-2020)
4.2 Global Iduronate 2 Sulfatase Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Iduronate 2 Sulfatase Market Size by Application (2015-2020)
5.2 Global Iduronate 2 Sulfatase Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Iduronate 2 Sulfatase Market Size (2015-2020)
6.2 Iduronate 2 Sulfatase Key Players in North America (2019-2020)
6.3 North America Iduronate 2 Sulfatase Market Size by Type (2015-2020)
6.4 North America Iduronate 2 Sulfatase Market Size by Application (2015-2020)

7 Europe
7.1 Europe Iduronate 2 Sulfatase Market Size (2015-2020)
7.2 Iduronate 2 Sulfatase Key Players in Europe (2019-2020)
7.3 Europe Iduronate 2 Sulfatase Market Size by Type (2015-2020)
7.4 Europe Iduronate 2 Sulfatase Market Size by Application (2015-2020)

8 China
8.1 China Iduronate 2 Sulfatase Market Size (2015-2020)
8.2 Iduronate 2 Sulfatase Key Players in China (2019-2020)
8.3 China Iduronate 2 Sulfatase Market Size by Type (2015-2020)
8.4 China Iduronate 2 Sulfatase Market Size by Application (2015-2020)

9 Japan
9.1 Japan Iduronate 2 Sulfatase Market Size (2015-2020)
9.2 Iduronate 2 Sulfatase Key Players in Japan (2019-2020)
9.3 Japan Iduronate 2 Sulfatase Market Size by Type (2015-2020)
9.4 Japan Iduronate 2 Sulfatase Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Iduronate 2 Sulfatase Market Size (2015-2020)
10.2 Iduronate 2 Sulfatase Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Iduronate 2 Sulfatase Market Size by Type (2015-2020)
10.4 Southeast Asia Iduronate 2 Sulfatase Market Size by Application (2015-2020)

11 India
11.1 India Iduronate 2 Sulfatase Market Size (2015-2020)
11.2 Iduronate 2 Sulfatase Key Players in India (2019-2020)
11.3 India Iduronate 2 Sulfatase Market Size by Type (2015-2020)
11.4 India Iduronate 2 Sulfatase Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Iduronate 2 Sulfatase Market Size (2015-2020)
12.2 Iduronate 2 Sulfatase Key Players in Central & South America (2019-2020)
12.3 Central & South America Iduronate 2 Sulfatase Market Size by Type (2015-2020)
12.4 Central & South America Iduronate 2 Sulfatase Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AngioChem
13.1.1 AngioChem Company Details
13.1.2 AngioChem Business Overview
13.1.3 AngioChem Iduronate 2 Sulfatase Introduction
13.1.4 AngioChem Revenue in Iduronate 2 Sulfatase Business (2015-2020))
13.1.5 AngioChem Recent Development
13.2 ArmaGen
13.2.1 ArmaGen Company Details
13.2.2 ArmaGen Business Overview
13.2.3 ArmaGen Iduronate 2 Sulfatase Introduction
13.2.4 ArmaGen Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.2.5 ArmaGen Recent Development
13.3 Bioasis Technologies
13.3.1 Bioasis Technologies Company Details
13.3.2 Bioasis Technologies Business Overview
13.3.3 Bioasis Technologies Iduronate 2 Sulfatase Introduction
13.3.4 Bioasis Technologies Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.3.5 Bioasis Technologies Recent Development
13.4 Green Cross
13.4.1 Green Cross Company Details
13.4.2 Green Cross Business Overview
13.4.3 Green Cross Iduronate 2 Sulfatase Introduction
13.4.4 Green Cross Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.4.5 Green Cross Recent Development
13.5 JCR Pharmaceuticals
13.5.1 JCR Pharmaceuticals Company Details
13.5.2 JCR Pharmaceuticals Business Overview
13.5.3 JCR Pharmaceuticals Iduronate 2 Sulfatase Introduction
13.5.4 JCR Pharmaceuticals Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.5.5 JCR Pharmaceuticals Recent Development
13.6 Esteve
13.6.1 Esteve Company Details
13.6.2 Esteve Business Overview
13.6.3 Esteve Iduronate 2 Sulfatase Introduction
13.6.4 Esteve Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.6.5 Esteve Recent Development
13.7 RegenxBio
13.7.1 RegenxBio Company Details
13.7.2 RegenxBio Business Overview
13.7.3 RegenxBio Iduronate 2 Sulfatase Introduction
13.7.4 RegenxBio Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.7.5 RegenxBio Recent Development
13.8 Sangamo BioSciences
13.8.1 Sangamo BioSciences Company Details
13.8.2 Sangamo BioSciences Business Overview
13.8.3 Sangamo BioSciences Iduronate 2 Sulfatase Introduction
13.8.4 Sangamo BioSciences Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.8.5 Sangamo BioSciences Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Iduronate 2 Sulfatase Introduction
13.9.4 Takeda Revenue in Iduronate 2 Sulfatase Business (2015-2020)
13.9.5 Takeda Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Iduronate 2 Sulfatase Key Market Segments
Table 2. Key Players Covered: Ranking by Iduronate 2 Sulfatase Revenue
Table 3. Ranking of Global Top Iduronate 2 Sulfatase Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Iduronate 2 Sulfatase Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Alpha L Iduronate Sulfate Sulfatase
Table 6. Key Players of Idursulfase
Table 7. Key Players of IDS
Table 8. Key Players of EC 3.1.6.13
Table 9. Global Iduronate 2 Sulfatase Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Iduronate 2 Sulfatase Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Iduronate 2 Sulfatase Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Iduronate 2 Sulfatase Market Share by Regions (2015-2020)
Table 13. Global Iduronate 2 Sulfatase Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Iduronate 2 Sulfatase Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Iduronate 2 Sulfatase Market Growth Strategy
Table 19. Main Points Interviewed from Key Iduronate 2 Sulfatase Players
Table 20. Global Iduronate 2 Sulfatase Revenue by Players (2015-2020) (Million US$)
Table 21. Global Iduronate 2 Sulfatase Market Share by Players (2015-2020)
Table 22. Global Top Iduronate 2 Sulfatase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iduronate 2 Sulfatase as of 2019)
Table 23. Global Iduronate 2 Sulfatase by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Iduronate 2 Sulfatase Product Solution and Service
Table 26. Date of Enter into Iduronate 2 Sulfatase Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 29. Global Iduronate 2 Sulfatase Market Size Share by Type (2015-2020)
Table 30. Global Iduronate 2 Sulfatase Revenue Market Share by Type (2021-2026)
Table 31. Global Iduronate 2 Sulfatase Market Size Share by Application (2015-2020)
Table 32. Global Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 33. Global Iduronate 2 Sulfatase Market Size Share by Application (2021-2026)
Table 34. North America Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 36. North America Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 37. North America Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 38. North America Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 39. North America Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 40. Europe Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 42. Europe Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 44. Europe Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 46. China Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 47. China Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 48. China Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 49. China Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 50. China Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 51. China Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 52. Japan Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 54. Japan Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 56. Japan Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 60. Southeast Asia Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 62. Southeast Asia Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 64. India Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 65. India Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 66. India Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 67. India Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 68. India Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 69. India Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Iduronate 2 Sulfatase Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Iduronate 2 Sulfatase Market Share (2019-2020)
Table 72. Central & South America Iduronate 2 Sulfatase Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Iduronate 2 Sulfatase Market Share by Type (2015-2020)
Table 74. Central & South America Iduronate 2 Sulfatase Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Iduronate 2 Sulfatase Market Share by Application (2015-2020)
Table 76. AngioChem Company Details
Table 77. AngioChem Business Overview
Table 78. AngioChem Product
Table 79. AngioChem Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 80. AngioChem Recent Development
Table 81. ArmaGen Company Details
Table 82. ArmaGen Business Overview
Table 83. ArmaGen Product
Table 84. ArmaGen Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 85. ArmaGen Recent Development
Table 86. Bioasis Technologies Company Details
Table 87. Bioasis Technologies Business Overview
Table 88. Bioasis Technologies Product
Table 89. Bioasis Technologies Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 90. Bioasis Technologies Recent Development
Table 91. Green Cross Company Details
Table 92. Green Cross Business Overview
Table 93. Green Cross Product
Table 94. Green Cross Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 95. Green Cross Recent Development
Table 96. JCR Pharmaceuticals Company Details
Table 97. JCR Pharmaceuticals Business Overview
Table 98. JCR Pharmaceuticals Product
Table 99. JCR Pharmaceuticals Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 100. JCR Pharmaceuticals Recent Development
Table 101. Esteve Company Details
Table 102. Esteve Business Overview
Table 103. Esteve Product
Table 104. Esteve Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 105. Esteve Recent Development
Table 106. RegenxBio Company Details
Table 107. RegenxBio Business Overview
Table 108. RegenxBio Product
Table 109. RegenxBio Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 110. RegenxBio Recent Development
Table 111. Sangamo BioSciences Business Overview
Table 112. Sangamo BioSciences Product
Table 113. Sangamo BioSciences Company Details
Table 114. Sangamo BioSciences Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 115. Sangamo BioSciences Recent Development
Table 116. Takeda Company Details
Table 117. Takeda Business Overview
Table 118. Takeda Product
Table 119. Takeda Revenue in Iduronate 2 Sulfatase Business (2015-2020) (Million US$)
Table 120. Takeda Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iduronate 2 Sulfatase Market Share by Type: 2020 VS 2026
Figure 2. Alpha L Iduronate Sulfate Sulfatase Features
Figure 3. Idursulfase Features
Figure 4. IDS Features
Figure 5. EC 3.1.6.13 Features
Figure 6. Global Iduronate 2 Sulfatase Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Iduronate 2 Sulfatase Report Years Considered
Figure 11. Global Iduronate 2 Sulfatase Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Iduronate 2 Sulfatase Market Share by Regions: 2020 VS 2026
Figure 13. Global Iduronate 2 Sulfatase Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Iduronate 2 Sulfatase Market Share by Players in 2019
Figure 16. Global Top Iduronate 2 Sulfatase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iduronate 2 Sulfatase as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Iduronate 2 Sulfatase Revenue in 2019
Figure 18. North America Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Iduronate 2 Sulfatase Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed


【掲載企業】

AngioChem、ArmaGen、Bioasis Technologies、Green Cross、JCR Pharmaceuticals、Esteve、RegenxBio、Sangamo BioSciences、Takeda

★調査レポート[世界のイズロン酸2スルファターゼ市場インサイト及び予測(~2026年)] (コード:QYR20NV12299)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のイズロン酸2スルファターゼ市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆